Virinchi Health Care Private Limited ceases to be wholly-owned subsidiary
Virinchi Limited's subsidiary, Virinchi Health Care Private Limited (VHPL), is no longer wholly-owned. Promoter Viswanath Kompella now holds 49% after converting 52,22,000 warrants issued on March 3, 2026. VHPL's FY25 turnover was ₹92.54 crore.
The change in subsidiary status, while not a sale of the entire undertaking, reduces the parent company's ownership percentage. This could have implications for consolidation, control, and future strategic decisions related to the subsidiary.
The announcement details a change in subsidiary status due to a preferential allotment of warrants to a promoter, which has been approved by shareholders. While it involves a related party transaction, it does not inherently indicate positive or negative financial performance or strategic direction for the parent company.
Virinchi Limited has announced updates regarding its subsidiary, Virinchi Health Care Private Limited (VHPL). Shareholders of Virinchi Limited approved, via postal ballot on February 23, 2026, an investment by a related party in VHPL and the issuance of Convertible Equity Warrants by VHPL. Subsequently, on February 25, 2026, shareholders of VHPL approved the issue of these warrants to a Promoter on a preferential basis.
As a result, the Board of Directors of VHPL, in a meeting on March 03, 2026, allotted 52,22,000 Convertible Equity Warrants to Mr. Viswanath Kompella, a Promoter. Each warrant entitles the holder to subscribe for one equity share of VHPL. The conversion of these warrants into equity shares was completed in two tranches: 48,85,000 warrants were converted on March 05, 2026, and the remaining 3,37,000 warrants were converted on March 09, 2026, resulting in a total of 52,22,000 equity shares issued to Mr. Viswanath Kompella.
Consequently, Virinchi Health Care Private Limited is no longer a wholly-owned subsidiary of Virinchi Limited, though it continues to remain a subsidiary. The shareholding of VHPL changed from Virinchi Limited holding 100% (54,35,978 shares) to Virinchi Limited holding 51% (54,35,978 shares) and Mr. Viswanath Kompella holding 49% (52,22,000 shares).
The turnover of VHPL for the financial year 2024-25 was ₹92.54 crore (30.73% of consolidated turnover), with a net worth of ₹(93.12 lakh). The total consideration received for the warrants was ₹7.83 crore, with the preferential allotment based on an enterprise valuation of VHPL at ₹312.08 crore. The transaction has been classified as a related party transaction, approved by shareholders through a postal ballot.
What to do with a filing like this
Virinchi Limited filed this with the NSE as a statutory disclosure, categorised under other corporate actions. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Virinchi Limited. Read the original for the full detail.